Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.35 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1240083 | 0.90 | TSHR (0.46) | ALDH1A1TSHRALOX5SMN1; SMN2TRPA1 | |
| SCHEMBL1017964 | 0.89 | — | — | |
| SCHEMBL19644551 | 0.88 | TSHR (0.50) | ALDH1A1TSHRALOX5SMN1; SMN2TRPA1 | |
| SCHEMBL19644556 | 0.88 | TSHR (0.50) | ALDH1A1TSHRALOX5SMN1; SMN2TRPA1 | |
| SCHEMBL1454741 | 0.87 | — | — | |
| SCHEMBL11328377 | 0.85 | — | — | |
| SCHEMBL1017004 | 0.85 | — | — | |
| SCHEMBL11330321 | 0.83 | TSHR (0.65) | ALDH1A1TSHRMAPT | |
| SCHEMBL1020050 | 0.81 | TSHR (0.39) | ALDH1A1TSHRTRPA1ABCC4MAPT | |
| SCHEMBL2122053 | 0.80 | ALDH1A1 (0.45) | ALDH1A1TSHRALOX5SMN1; SMN2TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111876748-A | Metal sulfide thin film based on organic sulfur precursor and preparation method thereof | 北京大学深圳研究生院 | 2020-11-03 | — | — | CN | claimed |
| CN-119684341-A | Double-ended organoaluminum compositions | 陶氏环球技术有限责任公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-4435013-A2 | PROCESS FOR PREPARING MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING | Dow Global Technologies LLC (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-3519474-B1 | PROCESS FOR PREPARING MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-3519456-B1 | CAPPED MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING AND PROCESS TO PREPARE THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-3732211-B1 | CAPPED DUAL-HEADED ORGANOALUMINUM COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-05-22 | — | — | EP | disclosed |
| CN-111433235-B | Capped double-ended organoaluminum compositions | 陶氏环球技术有限责任公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-109952324-B | Blocked multi-or double-headed compositions suitable for chain shuttling and methods of making the same | 陶氏环球技术有限责任公司 | 2023-06-09 | — | — | CN | disclosed |
| US-11613600-B2 | Capped dual-headed organoaluminum compositions | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-03-28 | — | — | US | disclosed |
| US-11492450-B2 | Dual-headed organoaluminum compositions | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-11-08 | — | — | US | disclosed |
| WO-2017205713-A1 | ALIPHATIC POLYSULFONES WITH IMPROVED MECHANICAL INTEGRITY | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2017-11-30 | — | — | WO | disclosed |
| EP-3243846-A2 | MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS | Dow Global Technologies Llc (US) | 2017-11-15 | — | — | EP | disclosed |
| EP-2459598-B1 | DUAL- OR MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-18 | — | — | EP | disclosed |
| CN-102498133-B | Bid-or multi-head chain shuttling agents and their use for the preparation of block copolymers | DOW GLOBAL TECHNOLOGIES INC | 2013-10-30 | — | — | CN | disclosed |
| US-8501885-B2 | Dual- or multi-headed chain shuttling agents and their use for preparation of block copolymers | DOW GLOBAL TECHNOLOGIES, LLC (US) | 2013-08-06 | — | — | US | disclosed |
| US-20120165486-A1 | DUAL- OR MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR PREPARATION OF BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-06-28 | — | — | US | disclosed |
| CN-102498133-A | Bid-or multi-head chain shuttling agents and their use for the preparation of block copolymers | DOW GLOBAL TECHNOLOGIES INC | 2012-06-13 | — | — | CN | disclosed |
| EP-2459598-A2 | DUAL- OR MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS | Dow Global Technologies LLC (US) | 2012-06-06 | — | — | EP | disclosed |
| WO-2011016991-A2 | DUAL- OR MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-02-10 | — | — | WO | disclosed |
| US-4683301-A | BACTERICIDES | BRISTOL-MYERS COMPANY (US) | 1987-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11613600-B2 | Capped dual-headed organoaluminum compositions | CAPG, C5, CDS2 | ALDH1A1 2097/4885TSHR 4645/4885ALOX5 285/4885 |
| US-20120165486-A1 | DUAL- OR MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR PREPARATION OF BLOCK COPOLYMERS | MSN, COASY, MCM7 | ALDH1A1 3614/4885TSHR 4812/4885ALOX5 606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.